Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Target Temperature Management on Drug Metabolism
2018-002226-22Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pantoprazole and erythromycin in cardiac arrest (SCA) and post-cardiac arrest syndrome (PCAS) (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Half-life of pantoprazole during cooling, Half-life of pantoprazole after rewarming and 6 more. Started Aug 2018; status: completed.
02
Drugs
pantoprazoleerythromycin
03
Conditions
cardiac arrest (SCA)post-cardiac arrest syndrome (PCAS)
Beyond the preview
Go deeper on 2018-002226-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002226-22.